Intracameral tissue plasminogen activator for treatment of excessive fibrin response after penetrating keratoplasty.
Snyder
R W
RW
Department of Ophthalmology, University of Arizona College of Medicine, Tucson 85724.
Sherman
M D
MD
Allinson
R W
RW
D000368:Aged; D000867:Anterior Chamber; D003320:Corneal Ulcer / Q000209:etiology / Q000601:surgery; D015818:Eye Infections, Bacterial / Q000150:complications; D005337:Fibrin / Q000378:metabolism*; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007267:Injections; D015948:Keratoplasty, Penetrating / Q000009:adverse effects*; D008297:Male; D011552:Pseudomonas Infections / Q000150:complications; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*
D005337:Fibrin; D010959:Tissue Plasminogen Activator